KaloCyte

BiotechnologyWebsite

Developer of red blood cell substitutes designed for trauma care-related services. The company's cell substitutes are designed for context-dependent oxygen delivery, while minimizing vasoconstriction ...

Biotechnology
Healthcare
Baltimore, MD, United States
20 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$5.7M
Last Round
Accelerator/Incubator
Jan 2020
Latest Funding Round
Accelerator/Incubator
Jan 1, 2020
View all funding rounds
Investors
+18 other investors
View all 18 investors
Valuation History
1 funding rounds on record
Cap Table
Ownership structure
Market Activity
Secondary transactions

Get the full picture

Create a free account to unlock KaloCyte's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required